| 1.77 -0.02 (-1.12%) | 03-04 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 4.61 | 1-year : | 6.26 |
| Resists | First : | 3.95 | Second : | 5.36 |
| Pivot price | 2.18 |
|||
| Supports | First : | 1.67 | Second : | 1.39 |
| MAs | MA(5) : | 1.84 |
MA(20) : | 2.24 |
| MA(100) : | 5.99 |
MA(250) : | 11.21 |
|
| MACD | MACD : | -0.7  |
Signal : | -0.8 |
| %K %D | K(14,3) : | 7 |
D(3) : | 5.3 |
| RSI | RSI(14): 30.3 |
|||
| 52-week | High : | 39 | Low : | 1.67 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AGPU ] has closed above bottom band by 11.4%. Bollinger Bands are 70% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.82 - 1.83 | 1.83 - 1.84 |
| Low: | 1.69 - 1.7 | 1.7 - 1.71 |
| Close: | 1.77 - 1.79 | 1.79 - 1.81 |
Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.
Fri, 27 Feb 2026
AGPU Price History for Axe Compute Stock - Barchart.com
Thu, 26 Feb 2026
AGPU Should I Buy - Intellectia AI
Tue, 24 Feb 2026
Owner of 150,000 tumor samples weighs what to do with its biobank - Stock Titan
Mon, 23 Feb 2026
Axe Compute Explores Strategic Options for its Helomics Business as Company Sharpens AI Compute Focus - Bitget
Thu, 22 Jan 2026
Axe Compute announces multiple board and executive resignations - TipRanks
Sat, 27 Dec 2025
What is the current Price Target and Forecast for Axe Compute Inc. (AGPU) - Zacks Investment Research
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Infrastructure
|
|
| Shares Out | 0 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 1.82e+006 (%) |
| Held by Institutions | 5 (%) |
| Shares Short | 89 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.08e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -90 % |
| Return on Assets (ttm) | 654 % |
| Return on Equity (ttm) | -128.9 % |
| Qtrly Rev. Growth | 1.66e+006 % |
| Gross Profit (p.s.) | -5.49 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 602993 |
| Qtrly Earnings Growth | -141.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.03 |
| Dividend | 0 |
| Forward Dividend | 156530 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|